Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
BroadSoft Inc. (NASDAQ: BSFT) shares spiked 6.73 percent to close at $29.96 a share last Wednesday. The stock traded between $28.05 and $30.20 on volume of 861,171 shares traded. The company announced that Sprint has selected its BroadWorks platform to enhance VoIP services. Shares of BroadSoft are up approximately 10.0 percent year-to-date.
Get more information on BroadSoft and free access to the in-depth equity report at:
www.FiveStarEquities.com/BSFT
Cinedigm Corp. (NASDAQ: CIDM) shares gained 5.81 percent to close at $2.55 a share last Wednesday. The stock traded between $2.32 and $2.56 on volume of 245,743 shares traded. The company announced that Palace Cinemas has agreed to use Cinedigm’s ENTERPRISE WEB in all of its existing and upcoming theaters. Shares of Cinedigm have gained approximately 25.0 percent year-to-date.
Get more information on Cinedigm and free access to the in-depth equity report at:
www.FiveStarEquities.com/CIDM
PolyOne Corporation (NYSE: POL) shares increased 5.50 percent to close at $35.50 a share last Wednesday. The stock traded between $33.36 and $3.97 on volume 2.22 million shares traded. The company reported $924 million in revenue for the fourth quarter of 2013, an increase of 42.0 percent when compared to a year ago. Shares of PolyOne have gained over 50.0 percent in the past year.
Get more information on PolyOne free access to the in-depth equity report at:
www.FiveStarEquities.com/POL
TherapeuticsMD Inc. (NYSEMKT: TXMD) shares jumped 6.12 percent to close at $6.24 a share last Wednesday. The stock traded between $5.50 and $6.48 on volume of 1.27 million shares traded. The company has reported positive study results of Vagicap, an experimental drug for the treatment of menopause symptoms. Shares of TherapeuticsMD have gained approximately 20.0 percent year-to-date.
Get more information on TherapeuticsMD and free access to the in-depth equity report at:
www.FiveStarEquities.com/TXMD
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]